To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. — HR-10628 (R-NY) · Congress.wiki
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
house
senate
president
Introduced September 28, 2026 by Nicholas A. Langworthy · Last progress September 28, 2026
